Comparing the Efficacy and Safety of Fremanezumab for Chronic Cluster Headache

Study Title

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Teva Identifier

TV48125-CNS-30057 | 2016-003171-21

ClinicalTrials.gov Identifier

NCT02964338

Study Status

Terminated

Trial Condition(s)

Chronic Cluster Headache

Interventions

Drug: Fremanezumab | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 70 Years

Trial Duration

January 17, 2017 - July 18, 2018

Phase

Phase 3

Additional info

Study Type

Interventional